Boothbay Fund Management »

Eyepoint Pharmaceuticals shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.8M 217k 12.89
2024-03-31 $5.1M 248k 20.67
2023-09-30 $744k 93k 7.99
2021-06-30 $347k 39k 9.00
2021-03-31 $145k 14k 10.19

More positions owned by Boothbay Fund Management

At&t Call Option (T)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Call Option (TSLA)
Abivax Sa Sponsored Ads (ABVX)
Ge Aerospace Com New Call Option (GE)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Cornerstone Strategic Value (CLM)
Mineralys Therapeutics Put Option (MLYS)
United Therapeutics Corporation Call Option (UTHR)
Constellation Brands Cl A Call Option (STZ)

View all positions for Boothbay Fund Management

Top funds holding Eyepoint Pharmaceuticals

Suvretta Capital Management
Cormorant Asset Management
BlackRock
Federated Investors
Franklin Resources
Vanguard Group
Adage Capital Partners GP
Henderson Group
Vanguard Capital Management
Paradigm Biocapital Advisors
Commodore Capital
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen

View all funds holding Eyepoint Pharmaceuticals